Clinical High Risk For Psychosis
📧 Sign up to get email alerts when something new happens for Clinical High Risk For Psychosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: Gabapentin in Patients at Clinical Risk for Psychosis [Phase 1, Phase 2]
A Phase 1/Phase 2 trial of gabapentin in individuals at clinical high risk for psychosis was terminated; results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Glutamate Reducing Interventions in Schizophrenia [Phase 1]
Phase 1 clinical trial update evaluating glutamate-reducing interventions for individuals at clinical high risk for psychosis; study complet…